The effect of Theiler's murine encephalomyelitis virus (TMEV) VP1 carboxyl region on the virusinduced central nervous system disease

References

• Blair W S, Semler B L. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase. J Virol 1991; 65: 6111–6123
   Google Scholar
• Boege U, Kobasa D, Onoderer S, Parks G D, Palmenberg A C, Scraba D G. Characterization of Mengo virus neutralization epitopes. Virology 1991; 181: 1–13
   Google Scholar
• Calenoff M A, Faaberg K S, Lipton H L. Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci USA 1990; 87: 978–982
   Google Scholar
• Fox G., Parry N R, Barnett P J, McGinn B, Rowlands D J, Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 1989; 70: 625–637
   PubMed Web of Science ®Google Scholar
• Fu J M, Rodriguez M, Roos R P. Strains from both Theiler's virus subgroups encode a determinant for demyelinaton. J Virol 1990a; 64: 6345–6348
   Google Scholar
• Fu J, Stein S, Rosenstein L, Bodwell Routbort T. M, Semler B L, Roos R P. Neurovirulence determinants of genetically engineered Theiler's viruses. Proc Natl Acad Sci USA 1990b; 87: 4125–4129
   Google Scholar
• Grant R A, Filman D J, Fuginami R S, Icenogle J P, Hogle J M. Three-dimensional structure of Theiler virus. Proc Natl Acad Sci 1992; 89: 2061–2065
   Google Scholar
• Hellen C UT, Lee C K, Wimmer E. Determinants of substrate recognition by poliovirus 2A proteinase. J Viral 1992; 66: 3330–3338
   Google Scholar
• Higuchi R. Recombinant PCR. PCR Protocols, M A Innis, D H Gelfand, J J Sninsky, T J White. Academic Press, San Diego, California 1990; 177–183
   Google Scholar
• Jarousse N, Grant R A, Hogle J H, Zhang L, Senkowski A, Roos R P, Michiels T, Brahic M, McAllister A. A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol 1994; 68: 3364–3368
   Google Scholar
• Karber G. Beitrag zur kollektiven Behandlung pharmakoligischer Reihenveruche. Arch Exp Pathol Pharmakol 1931; 162: 480–483
   Google Scholar
• Lawson M A, Semler B L. Picornavirus protein processing: enzymes, substrates, and genetic regulation. Curr Top Microbiol Immunol 1990; 161: 49–87
   PubMedGoogle Scholar
• Lee C K, Wimrner E. Proteolytic processing of poliovirus polyprotein: elimination of 2Apro-mediated alternative cleavage of polypeptide 3 CD by in vitro, mutagenesis. Virology 1988; 166: 405–414
   PubMed Web of Science ®Google Scholar
• Luo M, Vriend G, Kramer G, Minor J, Arnold E, Rossman M G, Boege U, Scraba D G, Duke G M, Palmenberg A C. The atomic structure of Mengo virus at 3.0 A resolution. Science 1987; 325: 182–191
   Google Scholar
• Nicklin M JH, Krausslich H G, Toyoda H, Dunn J J, Wimmer E. Poliovirus polypeptide precursors: expression in vitro, and processing by 3C and 2A proteinases. Proc Natl Acad SCi USA 1987; 84: 4002–4006
   Google Scholar
• Nitayaphan S, Toth M M, Roos R P. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses. J Virol 1985a; 56: 887–895
   Google Scholar
• Nitayaphan S, Toth M M, Roos R P. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis virus. J Virol 1985b; 53: 651–657
   Google Scholar
• Ohara Y, Senkowski A, Fu J, Klaman L, Goodall J, Toth M, Roos R P. Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J viral 1988; 62: 3527–3529
   Google Scholar
• Palmenberg A C. Proteolytic processing of picornaviral polyprotein. Annu Rev Microb 1990; 44: 603–623
   PubMed Web of Science ®Google Scholar
• Parks G D, Baker J C, Palmenberg A C. Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme. J Virol 1989; 63: 1054–1058
   Google Scholar
• Parks G D, Palmenberg A C. Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors. J Virol 1987; 61: 3680–3687
   Google Scholar
• Pevear D C, Luo M L, Lipton H L. Three-dimensional model of the capsid proteins of two biologically different Theiler's virus strains: clustering of amino acid differences identifies possible locations of immunogenic sites on the virion. Proc Natl Acad Sci USA 1988; 85: 4496–4500
   Google Scholar
• Pritchard A E, Jensen K, Lipton H L. Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J Virol 1993; 67: 3901–3907
   Google Scholar
• Rodriguez M, Roos R P. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol 1992; 66: 217–225
   Google Scholar
• Roivainen M, Hyypia T, Piirainden L, Kalkinen N, Stanway G, Hovi T. RGD-dependent entry of Coxsackie virus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J Virol 1991; 65: 4735–4740
   Google Scholar
• Roos R P, Casteel N. Determinants of neurological disease induced by Theiler's murine encephalomyelitis virus. Molecular Neurovirology: Pathogenesis of Central Nervous System Virus Infections, R P Roos. Humana Press, Totowa, New Jersey 1992; 283–317
   Google Scholar
• Roos R P, Kong W P, Semler B L. Polyprotein processing of Theiler's murine encephalomyelitis viruses. J Virol 1989; 63: 5344–5353
   Google Scholar
• Roos R P, Richards O C, Green J, Ehrenfeld E. Characterization of cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol 1982; 43: 1118–1122
   Google Scholar
• Roos R P, Stein S, Ohara Y, Fu J, Semler B L. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol 1989; 63: 5492–5496
   Google Scholar
• Roos R P, Stein S, Routbort M, Senkowski A, Bodwell T, Wollmann R. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol 1989; 63: 4469–4473
   Google Scholar
• Sanger F, Nicklers S, Carlson A R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–5467
   PubMed Web of Science ®Google Scholar
• Senkowski A. Controls of neutralization and pathogenesis for Theiler's murine encephalomyelitis virus. PhD thesis, University of Chicago, Chicago 1994
   Google Scholar
• Wild T F, Brown F. Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J Gen Viral 1967; 1: 246–250
   Google Scholar
• Ypma-Wong M F, Filman D J, Hogle J M, Semler B L. Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at gln-gly pairs. J Biol Chem 1988; 63: 17846–17856
   Google Scholar
• Ypma-Wong M F, Semler B L. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J Virol 1987; 613: 3181–3189
   Google Scholar
• Zhang L, Senkowski A, Shim B, Roos R P. Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J viral 1993; 67: 4404–4408
   Google Scholar
• Zurbriggen A, Thomas C, Yamada M, Roos R P, Fujinami R. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol 1991; 65: 1929–1937
   Google Scholar
• Zurbriggen A, Yamada M, Thomas C, Fujinami R J. Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol 1991; 65: 1023–1030
   Google Scholar